{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T05:25:35Z","timestamp":1775366735134,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010010","name":"Shanxi Province Science Foundation for Youths","doi-asserted-by":"publisher","award":["202203021212039"],"award-info":[{"award-number":["202203021212039"]}],"id":[{"id":"10.13039\/501100010010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.clinre.2025.102617","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T02:46:02Z","timestamp":1748486762000},"page":"102617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Interleukin-22 ameliorates alcohol-associated liver fibrosis via Nrf2-ARE signaling: mechanistic insights and clinical correlations"],"prefix":"10.1016","volume":"49","author":[{"given":"Xiaojuan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyou","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyan","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1708-6598","authenticated-orcid":false,"given":"Lijuan","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinre.2025.102617_bib0001","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176345","article-title":"Alcohol-associated liver disease","volume":"134","author":"Mackowiak","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2025.102617_bib0002","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2021.7683","article-title":"Diagnosis and treatment of alcohol-associated liver disease: a review","volume":"326","author":"Singal","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.clinre.2025.102617_bib0003","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","article-title":"Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2025.102617_bib0004","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.27406","article-title":"The global burden of liver disease: the major impact of China","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2025.102617_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013620","article-title":"Disparities between research attention and burden in liver diseases: implications on uneven advances in pharmacological therapies in Europe and the USA","volume":"7","author":"Ndugga","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinre.2025.102617_bib0006","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2025.102617_bib0007","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jhep.2018.12.003","article-title":"Fibrosis and alcohol-related liver disease","volume":"70","author":"Lackner","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2025.102617_bib0008","first-page":"939","article-title":"Guidelines of prevention and treatment for alcoholic liver disease: a 2018 update","volume":"34","year":"2018","journal-title":"J Clin Hepatol"},{"key":"10.1016\/j.clinre.2025.102617_bib0009","first-page":"2067","article-title":"Research advances in the role of oxidative stress in the development and progression of liver fibrosis","volume":"35","author":"Zhao","year":"2019","journal-title":"J Clin Hepatol"},{"key":"10.1016\/j.clinre.2025.102617_bib0010","doi-asserted-by":"crossref","first-page":"17756","DOI":"10.3748\/wjg.v20.i47.17756","article-title":"Pathogenesis of alcoholic liver disease: role of oxidative metabolism","volume":"20","author":"Ceni","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2025.102617_bib0011","first-page":"464","article-title":"Exendin-4 alleviates oxidative stress and liver fibrosis by activating Nrf2\/HO-1 in streptozotocin-induced diabetic mice","volume":"39","author":"Fang","year":"2019","journal-title":"J South Med Univ"},{"key":"10.1016\/j.clinre.2025.102617_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120111","article-title":"Nrf2\/Keap1\/ARE signaling: towards specific regulation","volume":"291","author":"Ulasov","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.clinre.2025.102617_bib0013","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00099-20","article-title":"The molecular mechanisms regulating the KEAP1-NRF2 pathway","volume":"40","author":"Baird","year":"2020","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.clinre.2025.102617_bib0014","first-page":"2817","article-title":"Research advances in antioxidants in the progression of alcoholic liver disease","volume":"35","author":"Chen","year":"2019","journal-title":"J Clin Hepatol"},{"key":"10.1016\/j.clinre.2025.102617_bib0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/hep.31031","article-title":"Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets","volume":"72","author":"Hwang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2025.102617_bib0016","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","article-title":"IL-10 Family Cytokines IL-10 and IL-22: from basic science to clinical translation","volume":"50","author":"Ouyang","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.clinre.2025.102617_bib0017","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3390\/biomedicines9121912","article-title":"Therapeutic opportunities of IL-22 in non-alcoholic fatty liver disease: from molecular mechanisms to clinical applications","volume":"9","author":"Zai","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.clinre.2025.102617_bib0018","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cyto.2016.08.023","article-title":"Role of Interleukin-22 in chronic liver injury","volume":"98","author":"Carmo","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.clinre.2025.102617_bib0019","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2019.11.013","article-title":"Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice","volume":"72","author":"Xiang","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2025.102617_bib0020","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hep.26916","article-title":"Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment","volume":"59","author":"Zhao","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2025.102617_bib0021","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1741-7015-10-102","article-title":"Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study","volume":"10","author":"Kronenberger","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.clinre.2025.102617_bib0022","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41423-018-0029-8","article-title":"Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects","volume":"16","author":"Tang","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.clinre.2025.102617_bib0023","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.31046","article-title":"An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated Hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2025.102617_bib0024","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4049\/jimmunol.1900656","article-title":"Nrf2 through aryl hydrocarbon receptor regulates IL-22 response in CD4+ T cells","volume":"206","author":"Lin","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.clinre.2025.102617_bib0025","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.3748\/wjg.v23.i11.2002","article-title":"Antioxidant axis Nrf2-Keap1-ARE ininhibition of alcoholic liver fibrosis by IL-22","volume":"23","author":"Ni","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.clinre.2025.102617_bib0026","article-title":"Nrf2-Mediated ferroptosis inhibition exerts a protective effect on acute-on-chronic liver failure","volume":"16","author":"Wu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"issue":"264","key":"10.1016\/j.clinre.2025.102617_bib0027","article-title":"Interleukin-22 regulating Kupffer cell polarization through STAT3\/Erk\/Akt crosstalk pathways to extenuate liver fibrosis","volume":"1","author":"Su","year":"2021","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.clinre.2025.102617_bib0028","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/j.gastro.2016.09.064","article-title":"Aryl hydrocarbon receptor ligands in cigarette smoke induce production of interleukin-22 to promote pancreatic fibrosis in models of chronic pancreatitis","volume":"151","author":"Xue","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2025.102617_bib0029","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","article-title":"Classification of chronic viral hepatitis: a need for reassessment","volume":"13","author":"Scheuer","year":"1991","journal-title":"J Hepatol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125000956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125000956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T15:12:26Z","timestamp":1754320346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740125000956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2210740125000956"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102617","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-22 ameliorates alcohol-associated liver fibrosis via Nrf2-ARE signaling: mechanistic insights and clinical correlations","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102617"}}